196 related articles for article (PubMed ID: 25083608)
1. The role of caveolin-1 and syndecan-4 in the internalization of PEGylated PAMAM dendrimer polyplexes into myoblast and hepatic cells.
Shen W; van Dongen MA; Han Y; Yu M; Li Y; Liu G; Banaszak Holl MM; Qi R
Eur J Pharm Biopharm; 2014 Nov; 88(3):658-63. PubMed ID: 25083608
[TBL] [Abstract][Full Text] [Related]
2. PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression.
Qi R; Gao Y; Tang Y; He RR; Liu TL; He Y; Sun S; Li BY; Li YB; Liu G
AAPS J; 2009 Sep; 11(3):395-405. PubMed ID: 19479387
[TBL] [Abstract][Full Text] [Related]
3. Efficient siRNA Delivery Using PEG-conjugated PAMAM Dendrimers Targeting Vascular Endothelial Growth Factor in a CoCl2-induced Neovascularization Model in Retinal Endothelial Cells.
Xu L; Shen W; Wang B; Wang X; Liu G; Tao Y; Qi R
Curr Drug Deliv; 2016; 13(4):590-9. PubMed ID: 26279119
[TBL] [Abstract][Full Text] [Related]
4. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of polyplex internalization into cells: testing the GM1/caveolin-1 lipid raft mediated endocytosis pathway.
Qi R; Mullen DG; Baker JR; Holl MM
Mol Pharm; 2010 Feb; 7(1):267-79. PubMed ID: 20025295
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
[TBL] [Abstract][Full Text] [Related]
7. Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers.
Tang Y; Li YB; Wang B; Lin RY; van Dongen M; Zurcher DM; Gu XY; Banaszak Holl MM; Liu G; Qi R
Mol Pharm; 2012 Jun; 9(6):1812-21. PubMed ID: 22548294
[TBL] [Abstract][Full Text] [Related]
8. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes.
Golkar N; Samani SM; Tamaddon AM
Int J Pharm; 2016 Aug; 510(1):30-41. PubMed ID: 27291973
[TBL] [Abstract][Full Text] [Related]
9. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
10. Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin.
Diaz C; Guzmán J; Jiménez VA; Alderete JB
Pharm Dev Technol; 2018 Sep; 23(7):689-696. PubMed ID: 28368674
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of efficient gene delivery systems by grafting pegylated alkylcarboxylate chains to PAMAM dendrimers: Evaluation of transfection efficiency and cytotoxicity in cancerous and mesenchymal stem cells.
Ayatollahi S; Hashemi M; Oskuee RK; Salmasi Z; Mokhtarzadeh A; Alibolandi M; Abnous K; Ramezani M
J Biomater Appl; 2015 Nov; 30(5):632-48. PubMed ID: 26265706
[TBL] [Abstract][Full Text] [Related]
12. Dependence of PEI and PAMAM Gene Delivery on Clathrin- and Caveolin-Dependent Trafficking Pathways.
Hwang ME; Keswani RK; Pack DW
Pharm Res; 2015 Jun; 32(6):2051-9. PubMed ID: 25511918
[TBL] [Abstract][Full Text] [Related]
13. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
[TBL] [Abstract][Full Text] [Related]
14. Targeting hepatic cancer cells with pegylated dendrimers displaying N-acetylgalactosamine and SP94 peptide ligands.
Medina SH; Tiruchinapally G; Chevliakov MV; Durmaz YY; Stender RN; Ensminger WD; Shewach DS; Elsayed ME
Adv Healthc Mater; 2013 Oct; 2(10):1337-50. PubMed ID: 23554387
[TBL] [Abstract][Full Text] [Related]
15. Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity.
Kim Y; Klutz AM; Jacobson KA
Bioconjug Chem; 2008 Aug; 19(8):1660-72. PubMed ID: 18610944
[TBL] [Abstract][Full Text] [Related]
16. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
[TBL] [Abstract][Full Text] [Related]
17. Effective tolerance to serum proteins of head-tail type polycation vectors by PEGylation at the periphery of the head block.
Harada A; Kimura Y; Kojima C; Kono K
Biomacromolecules; 2010 Apr; 11(4):1036-42. PubMed ID: 20201491
[TBL] [Abstract][Full Text] [Related]
18. PEGylated polyamidoamine dendrimers with bis-aryl hydrazone linkages for enhanced gene delivery.
Yuan Q; Yeudall WA; Yang H
Biomacromolecules; 2010 Aug; 11(8):1940-7. PubMed ID: 20593893
[TBL] [Abstract][Full Text] [Related]
19. Drug pH-sensitive release in vitro and targeting ability of polyamidoamine dendrimer complexes for tumor cells.
Liu D; Hu H; Zhang J; Zhao X; Tang X; Chen D
Chem Pharm Bull (Tokyo); 2011; 59(1):63-71. PubMed ID: 21212549
[TBL] [Abstract][Full Text] [Related]
20. Ultrafast in situ forming poly(ethylene glycol)-poly(amido amine) hydrogels with tunable drug release properties via controllable degradation rates.
Buwalda SJ; Bethry A; Hunger S; Kandoussi S; Coudane J; Nottelet B
Eur J Pharm Biopharm; 2019 Jun; 139():232-239. PubMed ID: 30954658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
